The effect of inhaled salbutamol on the pain intensity of patients with problems caused by acute renal colic: A double-blind clinical trial study.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231205060266N1

Enrollment

100

Registered

2024-04-18

Start date

2024-04-18

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute renal colic. Unspecified renal colic

Interventions

Intervention 1: Intervention group: These patients will be treated with 30 mg ketorolac by injection along with salbutamol nebulizer 10 puffs every 20 minutes, up to one hour. After 10 ,20 ,30 ,45 ,60

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Pain intensity based on Visual Analog Scale (VAS) in the medium range The patient's willingness to participate in the study and obtain informed consent The presence of clinical symptoms of renal colic along with at least one of the three cases of hematuria in the complete urine analysis test, seeing stones in radiography or ultrasound of the urinary tract.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of patients' pain. Timepoint: Measurement of pain intensity before the intervention, and at intervals of 10, 20, 30, 45, 60 and 120 minutes after the intervention. Method of measurement: Evaluation of pain intensity with Visual Analog Scale (VAS), evaluation of hemodynamic variables with monitoring device.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyyed Mohammad Hosseini Nejad

Mazandaran University of Medical Sciences

emamsari.hospital@gmail.com+98 11 3335 0670

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026